Every coffee keeps the site running. Thank you!
Tech, gaming and the news that matters
Clinical trials for small interfering RNA therapeutics targeting metabolic conditions have progressed to late-stage human testing following positive safety data.
Delivery System Advances
The deployment of lipid nanoparticle transport systems allows precise liver-targeted delivery, minimizing off-target systemic effects. If approved, these quarterly injectable therapies could displace daily oral medications for millions of patients with lipid disorders.
Pharmaceutical firms redirect R&D capital toward metabolic therapeutics as clinical trials show broader cardiovascular and kidney benefits.
High-throughput benchtop sequencers shorten patient screening times from weeks to days, reshaping clinical trial logistics.
The Law of attraction is the universal law that states – you receive what you want, virtually every…
The individuals who have this misconception will quite naturally get frustrated when strategy fails to function. But it’s…
A Dentist is a health care provider who deals with oral issues. The dentist is also called a…
Employers adjust health benefit plans as adoption of metabolic therapies increases operational costs.